Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus
Titel:
Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus
Auteur:
Evans, Marc Kozlovski, Plamen Paldánius, Päivi M. Foley, James E. Bhosekar, Vaishali Serban, Carmen Avogaro, Angelo